NM_000454.5:c.256G>C
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000454.5(SOD1):c.256G>C(p.Gly86Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G86S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000454.5 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spastic tetraplegia and axial hypotonia, progressiveInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SOD1 | NM_000454.5 | c.256G>C | p.Gly86Arg | missense_variant | Exon 4 of 5 | ENST00000270142.11 | NP_000445.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SOD1 | ENST00000270142.11 | c.256G>C | p.Gly86Arg | missense_variant | Exon 4 of 5 | 1 | NM_000454.5 | ENSP00000270142.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 1 Pathogenic:3
The SOD1 gene encodes superoxide dismutase-1, a cytoplasmic antioxidant enzyme that metabolizes superoxide radicals to molecular oxygen and hydrogen peroxide, thus providing a defense against oxygen toxicity.The p.Gly86Arg variant results in the substitution of a glycine residue with arginine at position 86 of the SOD1 protein. This missense mutation has been associated with the familial form of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease characterized by the loss of motor neurons in the brain and spinal cord. Studies have shown that the G85R SOD1 variant (equivalent to p.Gly86Arg due to the absence of the initial methionine in the protein sequence) induces motor neuron toxicity, although the exact mechanisms remain unclear .
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly86 amino acid residue in SOD1. Other variant(s) that disrupt this residue have been observed in individuals with SOD1-related conditions (PMID: 20075587), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this missense change affects SOD1 function (PMID: 15050437, 15208263, 16945901, 19165329, 20399791, 23280792, 24134191). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOD1 protein function. ClinVar contains an entry for this variant (Variation ID: 14758). This variant is also known as G85R. This missense change has been observed in individuals with autosomal dominant amyotrophic lateral sclerosis (PMID: 8446170, 20472325, 24908169, 32166880; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 86 of the SOD1 protein (p.Gly86Arg).
SOD1-related disorder Pathogenic:1
The SOD1 c.256G>C variant is predicted to result in the amino acid substitution p.Gly86Arg. This variant, which is also referred to as p.Gly85Arg in past reports using older genome reference builds, has been well-documented to be a cause of amyotrophic lateral sclerosis (Rosen et al. 1993. PubMed ID: 8446170; Prudencio et al. 2009. PubMed ID: 19483195; Chen et al. 2020. PubMed ID: 32166880). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at